British Menopause Society (BMS) – HRT Supply News BMS Tools for Clinicians HRT Guide HRT – Practical prescribing HRT preparations and equivalent alternatives Prescribable alternatives to HRT CKS HRT guide Serious Shortage Protocols [full list via NHS BSA – not searchable] Serious Shortage Protocols [‘Live’ list via PSNC – not searchable] PSNC Dispensing & Supply News [covers ALL Continue Reading »
The National Centre for Smoking Cessation & Training (NCSCT) has published the following bulletin notifying smoking cessation practitioners about problems with supplies of varenicline (Champix) and signposting to advice on alternatives. Champix out of stock We’ve been informed that unfortunately Pfizer are currently facing an issue with the supply of varenicline (Champix) across all doses and presentations. Pfizer Continue Reading »
The DHSC has reinstated publication of monthly reports and information on current issues affecting supply of medicines in England via the NHS Specialist Pharmacy Service website: https://www.sps.nhs.uk/articles/department-of-health-and-pharmaceutical-market-strategy-group-pmsg-supply-updates/ The monthly Supply Issues Updates for Primary and Secondary Care and linked documents are also circulated through the PrescQIPP network and form the core of the Notts APC COVID-19 Supply Issues Continue Reading »
The DHSC and NHSE&I jointly published a Guide to Managing Medicines Supply and Shortages in November 2019. The guide sets out the approach taken by the DHSC Medicines Supply Team and NHS&I Commercial Medicines Unit, with information on: intelligence; information gathering; risk assessment; categorisation; escalation routes; management options and communication methods. The DHSC and NHSE&I teams and the Continue Reading »
The Association of the British Pharmaceutical Industry have today [16/03/20] launched a ‘Responding to COVID-19‘ webpage, with information about the potential impact of the pandemic on the medicines supply chain and the steps being taken to safeguard supplies, including: The UK Government has asked pharmaceutical companies where possible to retain any remaining additional stockpiles of medicines that were Continue Reading »